Top Markets
Coin of the day
Bristol-Myers Squibb Company Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMY
Classement en actions #149
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and... Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Prix de l'action
$59.43
Capitalisation boursière
$121.03B
Changement (1 jour)
0.83%
Changement (1 an)
0.90%
Pays
US
Échange Bristol-Myers Squibb Company (BMY)

Catégorie

Historique du prix de l'action pour Bristol-Myers Squibb Company (BMY)
Prix de clôture le plus élevé : $59.62 le 2026-03-01

Prix de clôture le plus bas : $1.86 le 1972-06-01
Historique du prix de l'action de Bristol-Myers Squibb Company de 1972 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -4.27%
2025 -8.38%
2024 12.87%
2023 -32.99%
2022 27.36%
2021 -3.05%
2020 -0.97%
2019 20.53%
2018 -16.81%
2017 7.57%
2016 -16.13%
2015 15.50%
2014 14.61%
2013 59.12%
2012 -4.31%
2011 29.95%
2010 2.97%
2009 15.52%
2008 -22.11%
2007 10.50%
2006 15.64%
2005 -10.44%
2004 -8.12%
2003 7.53%
2002 -52.00%
2001 -20.92%
2000 4.21%
1999 5.46%
1998 33.69%
1997 69.70%
1996 31.37%
1995 44.78%
1994 -0.60%
1993 -15.26%
1992 -14.14%
1991 21.52%
1990 18.58%
1989 23.86%
1988 8.21%
1987 2.55%
1986 24.30%
1985 32.14%
1984 17.77%
1983 23.51%
1982 25.87%
1981 17.26%
1980 25.16%
1979 9.76%
1978 2.14%
1977 0.82%
1976 -5.66%
1975 44.75%
1974 -0.15%
1973 -28.62%
1972 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$896.62 9.12%
US
$183.40 151.78%
GB
$239.24 46.66%
US
$211.12 4.14%
US
$149.70 34.38%
CH